Home›Companies›Biotech & Pharma›NATSAR Pharmaceuticals

Natsar Pharmaceuticals, Inc.

Develops drug candidates for people with cancer and other diseases.

Updated Nov 10, 2026·Latest SEC filing May 8, 2026·Suggest an edit

About NATSAR Pharmaceuticals

NATSAR Pharmaceuticals is a private company based in Ellicott City, Maryland. It has reported $4,221,000 raised in one offering on Form D since May 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 23, 2026May 8, 2026$4,221,000target not set15$281KEquity, Tenant-in-commonRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on NATSAR Pharmaceuticals's Form D filed May 8, 2026.

Venu Raman
Venu Raman
Executive officer and director

Sources

  1. SECNatsar Pharmaceuticals, Inc. filing history